Filing Details
- Accession Number:
- 0001225208-13-022787
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-04 15:56:03
- Reporting Period:
- 2013-10-31
- Filing Date:
- 2013-11-04
- Accepted Time:
- 2013-11-04 15:56:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 78003 | Pfizer Inc | PFE | Pharmaceutical Preparations (2834) | 135315170 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1566333 | J Anthony Maddaluna | Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-11-01 | 43,500 | $25.87 | 103,627 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-11-01 | 2,000 | $31.04 | 101,627 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-11-01 | 6,300 | $31.03 | 95,327 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-11-01 | 35,200 | $31.02 | 60,127 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Phantom Stock Units SSP | Acquisiton | 2013-10-31 | 187 | $30.69 | 187 | $0.00 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-11-01 | 43,500 | $0.00 | 43,500 | $25.87 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 39,478 | No | 4 | A | Direct | ||
| 0 | 2017-02-21 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 46,440 | Indirect | By Rule 16b-3 Plan |
Footnotes
- Each unit represents one phantom share of common stock.
- These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
- These options are fully exercisable.
Billionaire Hedge Funds
